DRKS00033127已完成Unknown
Pharmacist-assisted implementation of guideline recommendations for QTc monitoring during psychopharmacotherapy - a prospective, randomised feasibility study - PHARMQT
Zentrum für Integrative Psychiatrie0 个研究点目标入组 160 人开始时间: 2023年11月28日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Admission to wards B3.01, B3.11, B6.01 and to the day clinic B22
- •- Expected length of stay at least 30 days
- •- Use of at least one QT-prolonging drug during the stay (known, possible or conditional risk according to CredibleMeds)
- •- Signed declaration of consent
排除标准
- •- Patients who are not taking a QT-prolonging drug during the study period
- •- Patients who sleep on the psychiatric wards but who are hospitalized for somatic treatment
研究者
相似试验
尚未招募
不适用
Impact of Pharmaceutical care in heart failure patientsCTRI/2022/10/046436Dr Anu Philip
尚未招募
Unknown
Implementation of Clinical Practice Guidelines for the Physiotherapy Management of People with Spinal Cord InjurySpinal Cord InjuryNeurological - Other neurological disordersPublic Health - Health service researchPhysical Medicine / Rehabilitation - PhysiotherapyInjuries and Accidents - Other injuries and accidentsACTRN12623001106628orthern Sydney Local Health District10
尚未招募
不适用
Pharmacist led decision support protocol for the management of anaemia utilising erythrocyte stimulating agents in patients undergoing haemodialysis.anaemia in renal diseaseACTRN12618000189224niversity of Queensland72
已完成
不适用
Development of intervention tool and its effect on health care of patients with dyslipidemia by community pharmacistsDyslipidemiaJPRN-UMIN000044945Showa University40
尚未招募
不适用
A combined, tailored pharmacist intervention with dose optimization of phosphate binding drugs to improve phosphate control in patients on dialysis.NL-OMON24286Franciscus Gasthuis and Vlietland45